摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-叔丁氧羰基-7-氮杂吲哚-3-硼酸频哪醇酯 | 942070-47-5

中文名称
1-叔丁氧羰基-7-氮杂吲哚-3-硼酸频哪醇酯
中文别名
——
英文名称
tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-1-carboxylate
英文别名
tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-b]pyridine-1-carboxylate
1-叔丁氧羰基-7-氮杂吲哚-3-硼酸频哪醇酯化学式
CAS
942070-47-5
化学式
C18H25BN2O4
mdl
——
分子量
344.218
InChiKey
FWSVXYOMGFESAP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    115-117 °C
  • 沸点:
    460.9±48.0 °C(Predicted)
  • 密度:
    1.13±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.12
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    62.6
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2934999090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:0dfe2919352266cd282b2f6b87ae1bb6
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 1-BOC-7-Azaindole-3-boronic acid, pinacol ester
Synonyms: tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-1-carboxylate

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 1-BOC-7-Azaindole-3-boronic acid, pinacol ester
CAS number: 942070-47-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, under −20◦C.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C18H25BN2O4
Molecular weight: 344.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-叔丁氧羰基-7-氮杂吲哚-3-硼酸频哪醇酯三氟乙酸 、 sodium carbonate 作用下, 以 二氯甲烷 为溶剂, 反应 2.0h, 以76%的产率得到3-(4,4,5,5-四甲基-1,3,2-二氧硼烷-2-基)-1H-吡咯并[2,3-B]吡啶
    参考文献:
    名称:
    铱催化的杂芳烃的 C-H 硼化:范围、区域选择性、后期功能化的应用和机制
    摘要:
    报道了铱催化杂芳烃的 CH 硼化的研究。发现几种含有多个杂原子的杂芳烃适合由铱 (I) 前体和四甲基菲咯啉的组合催化的 CH 硼化。对反应范围的研究导致了预测硼化的区域选择性的强大规则的发展,其中最重要的是硼化发生在氮原子的远端。报告了原位形成的杂芳基硼酸酯的一锅官能化,证明了所报告的方法对合成复杂杂芳基结构的有用性。还展示了这种方法在生物活性化合物的合成和后期功能化中的应用。机理研究表明,碱性杂芳烃可以与催化剂结合,并将在芳烃硼化过程中观察到的烯烃结合复合物的静止状态改变为含有结合杂芳烃的物质,从​​而导致催化剂失活。对观察到的区域选择性起源的研究表明,由于快速的 NH 硼酸化,硼酸化发生在 NH 键的远端,为与这些键相邻的硼酸化创造了不利的空间环境。计算研究和机理研究表明,与碱性氮相邻的 CH 键缺乏可观察到的硼化并不是在 CH 活化之前与庞大的路易斯酸配位的结果,
    DOI:
    10.1021/ja412563e
  • 作为产物:
    描述:
    参考文献:
    名称:
    新型美林素衍生物作为快速的细胞凋亡诱导剂。
    摘要:
    具有多激酶抑制剂活性的3-(杂)芳基取代的7-氮杂吲哚可通过一锅增田(Masuda)硼酸酯化-铃木偶联序列容易地获得。几种有前途的衍生物被确定为凋亡诱导剂,并强调了多激酶的抑制潜力,为鞘氨醇激酶2抑制剂。我们的测量结果提供了对美丽素衍生物的结构-活性关系的更多见解,表明带有吡啶部分带有2位氨基的吡啶部分的衍生物是最有活性的抗癌化合物,因此是未来体内研究的极有希望的候选者。
    DOI:
    10.1016/j.bmc.2019.06.029
点击查看最新优质反应信息

文献信息

  • TYK2 INHIBITORS AND USES THEREOF
    申请人:Nimbus Lakshmi, Inc.
    公开号:US20200131201A1
    公开(公告)日:2020-04-30
    The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
    本发明提供了化合物、其组合物以及使用它们来抑制TYK2并治疗TYK2介导的疾病的方法。
  • [EN] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS<br/>[FR] COMPOSÉS INDOLIQUES UTILES EN TANT QUE MODULATEURS DU RÉCEPTEUR DES ANDROGÈNES
    申请人:NIDO BIOSCIENCES INC
    公开号:WO2022020342A1
    公开(公告)日:2022-01-27
    Provided herein are compounds of formula (V) that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy's disease.
    本文提供了一种公式(V)的化合物,它们与雄激素受体(AR)的BF3结合,可以调节AR以治疗肯尼迪病。
  • Rapid synthesis of bis(hetero)aryls by one-pot Masuda borylation–Suzuki coupling sequence and its application to concise total syntheses of meridianins A and G
    作者:Eugen Merkul、Elisabeth Schäfer、Thomas J. J. Müller
    DOI:10.1039/c1ob05310h
    日期:——
    3-(Hetero)aryl substituted indoles, 7-azaindoles, and pyrroles can be obtained in a very concise fashion via a one-pot Masuda borylation–Suzuki coupling sequence. The concise total syntheses of the marine natural products meridianins A (5) and G (4i) nicely illustrate the utility of this methodology.
    通过一锅增田(Masuda)硼酸酯化-铃木(Suzuki)偶联序列可以非常简明的方式获得3-(杂)芳基取代的吲哚,7-氮杂吲哚和吡咯。海洋天然产物子午线素A(5)和G(4i)的简洁的总合成很好地说明了该方法的实用性。
  • Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors
    作者:Scott H. Henderson、Fiona Sorrell、James Bennett、Oleg Fedorov、Marcus T. Hanley、Paulo H. Godoi、Roberta Ruela de Sousa、Sean Robinson、Alexander Ashall-Kelly、Iva Hopkins Navratilova、Daryl S. Walter、Jonathan M. Elkins、Simon E. Ward
    DOI:10.1021/acs.jmedchem.1c01115
    日期:2021.8.12
    pyrazolo[1,5-b]pyridazine inhibitors with excellent ligand efficiencies, good physicochemical properties, and a high degree of selectivity over the kinome. Compound 11 exhibited good permeability and cellular activity without P-glycoprotein liability, extending the utility of 11 in an in vivo setting. These pyrazolo[1,5-b]pyridazines are a viable lead series in the discovery of new therapies for the
    双特异性酪氨酸调节激酶​​ 1A (DYRK1A) 调节大脑发育过程中神经元祖细胞的增殖和分化。因此,DYRK1A 作为治疗神经退行性疾病(包括阿尔茨海默病(AD)和唐氏综合症)的靶标引起了人们的兴趣。最近,DYRK1A 的抑制已被研究为糖尿病的潜在治疗方法,而 DYRK1A 作为细胞周期介质的作用引起了人们对肿瘤适应症的兴趣。构效关系(SAR)分析与高分辨率X射线晶体学相结合,产生了一系列吡唑并[1,5- b ]哒嗪抑制剂,具有优异的配体效率、良好的理化性质以及对其他药物的高度选择性。激酶。化合物11表现出良好的渗透性和细胞活性,且无需 P-糖蛋白,从而扩展了11在体内环境中的效用。这些吡唑并[1,5- b ]哒嗪是发现治疗与 DYRK1A 功能相关疾病的新疗法的可行的先导系列。
  • One-Pot Synthesis of Diazine-Bridged Bisindoles and Concise Synthesis of the Marine Alkaloid Hyrtinadine A
    作者:Boris O. A. Tasch、Eugen Merkul、Thomas J. J. Müller
    DOI:10.1002/ejoc.201100680
    日期:2011.8
    N-Boc-protected 3-iodoindoles and 3-iodo-7-azaindole in a pseudo three-component reaction involving a one-pot Masuda borylation–Suzuki arylation sequence. Some of the title compounds display promising cytotoxic properties. The versatility of this methodology is illustrated by a very concise total synthesis of the marine alkaloid hyrtinadine A.
    二嗪桥连的双吲哚很容易从 N-Boc 保护的 3-碘代吲哚和 3-碘-7-氮杂吲哚在伪三组分反应中获得,该反应涉及一锅 Masuda 硼酸化 - Suzuki 芳基化序列。一些标题化合物显示出有希望的细胞毒性特性。海洋生物碱 hyrtinadine A 的非常简洁的全合成说明了这种方法的多功能性。
查看更多

同类化合物

(4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 骆驼蓬酸 顺-六氢-1H-吡咯并[3,2-B]吡啶-4(2H)-羧酸叔丁基酯 螺哌啶-4,3’-3H吡咯并[2,3-b]吡啶-2’(1’H)-酮 螺[哌啶-4,3'-吡咯并[2,3-B]吡啶]-2'(1'H)-酮盐酸盐 莫西沙星杂质69 苹果酸法米替尼 苯乙胺,a,4-二甲基-b-苯基- 苄基-11氢吡咯并[3,4-B]吡啶 罗沙布林 甲基6-甲酰基-1-甲基-1H-吡咯并[3,2-b]吡啶-2-羧酸酯 甲基5-氰基-1H-吡咯并[2,3-b]吡啶-2-羧酸酯 甲基1H-吡咯并[2,3-B]吡啶-5-甲酸酯 甲基-1-甲氧基-4-吡咯并[3,2-c]吡啶 甲基 5-硝基-1H-吡咯并[2,3-B]吡啶-2-羧酸 环戊二烯并[4,5]吡咯并[2,3-B]吡啶,5,6,7,8-四氢 氧代-(1H-吡咯并[2,3-b]吡啶-3-基)-乙酸甲酯 培西达替尼盐酸盐 培西达替尼 吲嗪 吲哚嗪-6-羧酸乙酯 吲哚嗪-3-甲腈 吲哚嗪-2-羧酸甲酯 吲哚嗪-2-羧酸 叔丁基八氢-1H-吡咯并[2,3-c]吡啶-6-羧酸盐 叔丁基5-溴-7-氯-3-碘-1H-吡咯并[2,3-c]吡啶-1-羧酸盐 叔丁基5-溴-7-氯-1H-吡咯并[2,3-c]吡啶-1-羧酸盐 叔丁基3-甲酰基-5-甲基-1H-吡咯并[2,3-b]吡啶-1-羧酸盐 叔丁基3-(3-羟丙基-1-炔基)-5-甲基-1H-吡咯并[2,3-b]吡啶-1-羧酸盐 叔丁基(5-甲基-1H-吡咯并[2,3-b]吡啶-3-基)氨基甲酸酯 叔丁基((5-氟代-1H-吡咯并[2,3-b]吡啶-4-基)甲基氨基甲酸酯 反式-六氢-1H-吡咯并[3,4-C]吡啶-5(6H)-羧酸叔丁酯 化合物 T28221 八氢吡咯并[3.4-b]吡啶-1-羧酸叔丁酯 八氢吡咯并[3,4-b]吡啶 八氢-吡咯[3,4-C]吡啶-2-甲酸叔丁酯 八氢-6-(苯基甲基)-1H-吡咯并[3,4-b]吡啶-1-羧酸 1,1-二甲基乙酯 八氢-1H-吡咯并[3,4-C]吡啶 二苯基(吡咯并[2,3-b]吡啶-1-基)膦 二乙基1H-吡咯并[2,3B]吡啶-2,6-二甲酸基酯 乙基7-氯-3-甲基-1H-吡咯并[3,2-b]吡啶-2-甲酸基酯 乙基7-氮杂吲哚-4-羧酸酯 乙基4-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-吡咯并[2,3-b]吡啶-2-羧酸酯 乙基3-氨基-2-吲嗪羧酸酯 乙基1-乙基-1H-吡咯并[3,2-c]吡啶-6-羧酸酯 中氮茚-7-羧酸甲酯 中氮茚-6-羧酸 中氮茚-1-甲酸甲酯 中氮茚-1-甲酸 中氮茚,1-[[4-(3-溴丙氧基)苯基]磺酰]-2-乙基-